PDZK Antibodies

Santa Cruz Biotechnology provides a broad selection of PDZK monoclonal antibodies for various research applications. PDZK monoclonal antibodies are validated for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PDZK, or PDZ domain-containing protein, plays a crucial role in cellular signaling and protein interactions, influencing processes such as cell adhesion and signal transduction. PDZK has emerged as a significant research target due to its involvement in maintaining cellular architecture and function. Research involving PDZK has revealed important implications in cancer development and cardiovascular diseases. Scientists worldwide utilize PDZK monoclonal antibodies to explore molecular mechanisms and pathways in cell biology. PDZK monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific knowledge and contribute to breakthrough discoveries in biomedical research. The reliability and specificity of PDZK monoclonal antibodies support the scientific community in uncovering new insights into cellular processes and disease mechanisms.